Acquisition - August 22, 2014
Pfizer could set eyes on AstraZeneca again
Pfizer could still be interested in buying AstraZeneca, reports Bloomberg refering to individuals with insight into the matter. Pfizer may not get a great shot at buying AstraZeneca this fall but it’s however preparing to give it a try. Meanwhile, Bloomberg reports, the U.S.-based drug giant is looking at Actavis among other targets. The Pfizer management […]
Acquisition - August 19, 2014
Recipharm acquires Corvette Pharmaceutical Services Group
The Swedish contract development and manufacturing organisation Recipharm has signed an agreement to acquire Milan based Corvette Pharmaceutical Services Group for SEK 1.1 billion. The sellers of Corvette Group are LBO Italia Investimenti Srl (“LBO Italia”), as controlling shareholder, and some private investors, holding minority interests. Corvette Pharmaceutical Services Group (consisting of Corvette Group SpA and […]
Acquisition - August 5, 2014
Roche to buy Santaris Pharma
Swiss Roche has announced that the company has agreed to acquire Danish biopharmaceutical firm Santaris Pharma for USD 450 million. The plan is to expand discovery and development of RNA-targeting medicines. Santaris Pharma has pioneered its proprietary Locked Nucleic Acid (LNA) platform that has contributed to an emerging era of RNA-targeting therapeutics, according to Roche which […]
Acquisition - July 31, 2014
Meda acquires Rottapharm
Meda has entered into a definitive agreement to acquire Italian firm Rottapharm for a consideration of SEK 21.2 billion. The consideration will comprise SEK 15.3 billion (€1.643 billion) in cash, 30 million Meda shares corresponding to a value of SEK 3.3 billion (€357 million) and a non-contingent deferred payment in January 2017 of SEK 2.6 billion […]
Acquisition - July 26, 2014
Elekta acquires Mesi Medikal
Elekta has acquired the Turkish distributor of radiation oncology solutions Mesi Medikal A.S. Signing and closing of the acquisition took place on July 24, 2014. Mesi Medikal will change its name to Elekta and will be a fully owned company. The acquisition of Mesi Medikal is expected to add approximately 0.3% to Elekta’s revenues on an annual basis. The […]
Acquisition - June 5, 2014
Small Uppsala company in large deal
The smaller family company Namtall, a sister company to Medeca Pharma AB, has entered a large deal with pharmaceutical giant Valeant Pharmaceuticals. The deal, worth SEK 760 million (USD 115 million) plus royalties, regards the licensing rights for the sales of adrenalin pens for the treatment of allergic reactions. The medtech company Namtall from Uppsala […]
